A detailed history of Smithfield Trust CO transactions in Viatris Inc stock. As of the latest transaction made, Smithfield Trust CO holds 4,498 shares of VTRS stock, worth $58,474. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,498
Previous 4,010 12.17%
Holding current value
$58,474
Previous $41,000 21.95%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$10.32 - $12.13 $5,036 - $5,919
488 Added 12.17%
4,498 $50,000
Q1 2024

May 07, 2024

SELL
$11.27 - $13.53 $552 - $662
-49 Reduced 1.21%
4,010 $46,000
Q4 2023

Feb 07, 2024

SELL
$8.77 - $10.85 $1,280 - $1,584
-146 Reduced 3.47%
4,059 $43,000
Q3 2023

Nov 06, 2023

SELL
$9.59 - $11.35 $3,816 - $4,517
-398 Reduced 8.65%
4,205 $41,000
Q2 2023

Aug 08, 2023

SELL
$9.02 - $10.29 $2,453 - $2,798
-272 Reduced 5.58%
4,603 $46,000
Q1 2023

May 11, 2023

BUY
$9.2 - $12.26 $5,731 - $7,637
623 Added 14.65%
4,875 $45,000
Q4 2022

Feb 13, 2023

SELL
$8.72 - $11.56 $6,714 - $8,901
-770 Reduced 15.33%
4,252 $45,000
Q3 2022

Nov 14, 2022

SELL
$8.48 - $11.13 $2,026 - $2,660
-239 Reduced 4.54%
5,022 $40,000
Q2 2022

Aug 11, 2022

SELL
$9.95 - $12.27 $3,094 - $3,815
-311 Reduced 5.58%
5,261 $50,000
Q1 2022

May 16, 2022

SELL
$9.81 - $15.4 $9 - $15
-1 Reduced 0.02%
5,572 $54,000
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $3,143 - $3,816
-260 Reduced 4.46%
5,573 $67,000
Q3 2021

Nov 12, 2021

SELL
$13.25 - $15.13 $4,226 - $4,826
-319 Reduced 5.19%
5,833 $69,000
Q2 2021

Jul 26, 2021

SELL
$12.97 - $16.15 $4,980 - $6,201
-384 Reduced 5.88%
6,152 $88,000
Q1 2021

May 14, 2021

SELL
$13.59 - $18.54 $68,045 - $92,829
-5,007 Reduced 43.38%
6,536 $91,000
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $165,064 - $216,315
11,543 New
11,543 $216,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Smithfield Trust CO Portfolio

Follow Smithfield Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithfield Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Smithfield Trust CO with notifications on news.